The latest news updates from the 2024 Symposium
-
Treatment Post-CDK 4/6 Inhibitors – Presenter Profile
Read More: Treatment Post-CDK 4/6 Inhibitors – Presenter ProfileCarlos H. Barrios, MD, discusses a Tuesday afternoon presentation on single agent endocrine therapy post-CDK 4/6 inhibitors in metastatic HR+ breast cancer.
-
Poster Spotlight Session 1: Less is More: Minimizing Surgical Treatment in Patients with Early Stage Breast Cancer – Presenter Profile
Read More: Poster Spotlight Session 1: Less is More: Minimizing Surgical Treatment in Patients with Early Stage Breast Cancer – Presenter ProfileJai Min Ryu, MD, PhD, discusses a Tuesday evening poster presentation on the clinicopathologic characteristics and axillary lymph node status of patients enrolled in the NAUTILUS trial.
-
Poster Spotlight Session 2: Improving QOL and Care Delivery for the Breast Cancer Patient – Presenter Profile
Read More: Poster Spotlight Session 2: Improving QOL and Care Delivery for the Breast Cancer Patient – Presenter ProfileBruce Mann, MBBS, PhD, FRACS, discusses a Tuesday evening poster presentation on the impact of treatment de-escalation on fear of cancer recurrence and health-related quality of life.
-
Poster Spotlight Session 3: Insights from Single Cell, Spatial, and Artificial Intelligence Approaches – Presenter Profiles
Read More: Poster Spotlight Session 3: Insights from Single Cell, Spatial, and Artificial Intelligence Approaches – Presenter ProfilesFabiana Napolitano, MD; Carmen van Dooijeweert, MD, PhD; and Marcelo Sobral-Leite, PharmD, PhD, discuss their Tuesday evening poster presentations.